Novem Group’s Endovia Health Sciences, Inc. EDVA Stock Holding History

Novem Group’s Portfolio EDVA Stock Details EDVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-388	Closed	-$9.98K	–	400
2024 Q4	$9.98K	Buy	+388	New	+$12.9K	﹤0.01%	377

Other funds holding EDVA

Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Novem Group's EDVA Position: Q1 2025 in Review

Novem Group sold out of Endovia Health Sciences, Inc. (EDVA) in Q1 2025, closing a stake of 388 shares — an estimated $9.98K sold.

Novem Group first reported a position in EDVA in Q4 2024 and held it in 1 quarter. The position peaked at $9.98K in Q4 2024. 11 funds tracked by Wall St. Rank hold EDVA as of Q1 2025.

Novem Group reported no remaining Endovia Health Sciences, Inc. position as of Q1 2025 after selling out during the quarter.
Novem Group sold 388 Endovia Health Sciences, Inc. shares in Q1 2025, an estimated $9.98K.
Novem Group first reported a position in Endovia Health Sciences, Inc. in Q4 2024 and held it in 1 quarter.
Novem Group's Endovia Health Sciences, Inc. position peaked at $9.98K in Q4 2024.
11 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q1 2025.

Based on Novem Group's 13F filing for Q1 2025, filed 28 Apr 2025.